Li Li-wen, CHEN Lu-yuan. Influence of RAS Inhibitors in Patients at High Risk for Cardiovascular Events (ONTARGET Trial)[J]. Journal of Evidence-Based Medicine, 2008, 8(6): 324-326. DOI: 10.3969/j.issn.1671-5144.2008.06.002
|
Citation:
|
Li Li-wen, CHEN Lu-yuan. Influence of RAS Inhibitors in Patients at High Risk for Cardiovascular Events (ONTARGET Trial)[J]. Journal of Evidence-Based Medicine, 2008, 8(6): 324-326. DOI: 10.3969/j.issn.1671-5144.2008.06.002
|
Li Li-wen, CHEN Lu-yuan. Influence of RAS Inhibitors in Patients at High Risk for Cardiovascular Events (ONTARGET Trial)[J]. Journal of Evidence-Based Medicine, 2008, 8(6): 324-326. DOI: 10.3969/j.issn.1671-5144.2008.06.002
|
Citation:
|
Li Li-wen, CHEN Lu-yuan. Influence of RAS Inhibitors in Patients at High Risk for Cardiovascular Events (ONTARGET Trial)[J]. Journal of Evidence-Based Medicine, 2008, 8(6): 324-326. DOI: 10.3969/j.issn.1671-5144.2008.06.002
|
DownLoad: